Cyrielle L. Bouchez
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Cyrielle L. Bouchez has a total of 49 co-authors. Here are the top co-authors by number of shared publications:
- Anne Devin
CNRS, Institut de Biochimie et Génétique Cellulaires, UMR 5095, F-33000 Bordeaux, France
4 shared publications - Arnaud Mourier
University of Bordeaux, CNRS, Institut de Biochimie et Génétique Cellulaires (IGBC) UMR, Bordeaux, France
3 shared publications Michel Rigoulet
CNRS, Institut de Biochimie et Génétique Cellulaires, UMR 5095, Bordeaux, France
3 shared publications- Thomas Daubon
University of Bordeaux, CNRS, IBGC, UMR5095, Bordeaux, France
3 shared publications M. Rigoulet
CNRS, Institut de Biochimie et Génétique Cellulaires, UMR 5095, F-33000 Bordeaux, France; Université de Bordeaux, Institut de Biochimie et Génétique Cellulaires, UMR 5095, F-33000 Bordeaux, France
2 shared publications- Stéphane Duvezin-Caubet
Adolf-Butenandt-Institut für Physiologische Chemie, Ludwig-Maximilians-Universität München, Butenandtstr. 5, 81377 München, Germany
2 shared publications
Latest Publications
- 4 April 2026
- Published by Agence Bibliographique de l'Enseignement Supérieur
Étude de la régulation de la biogénèse mitochondriale chez la levure Saccharomyces cerevisiae
Dans la cellule, les fonctions cellulaires majeures, telles que la prolifération cellulaire, impliquent une consommation très importante d’énergie sous forme d’Adénosine Triphosphate (ATP). Pour répondre à l’augmentation de la demande énergétique, une production continuelle d’ATP est nécessaire. Dans ce contexte, les mitochondries sont les principaux producteurs d’ATP via le système des oxydations phosphorylantes (ou OXPHOS). Ce système couple l’activité de la chaine respiratoire (consommation d’oxygène) à celle de l’ATP synthase grâce au gradient électrochimique en protons de part et d’autre de la membrane interne mitochondriale. Ceci fait de la mitochondrie un élément central qui peut être régulé pour s’adapter aux demandes énergétiques de la cellule. En effet, une régulation cinétique de l’activité de la mitochondrie peut mener à une régulation plus globale du flux de production d’ATP tout comme une régulation du nombre de mitochondries au sein la cellule. Le réseau mitochondrial dans la cellule est géré par deux phénomènes : leur synthèse (biogénèse) et leur dégradation (ou mitophagie). Dans la souche de levure S. cerevisiae, la biogénèse mitochondriale est contrôlée par un hétérotétramère formé par les facteurs de transcription Hap2/3/4/5. L’activation du complexe dépend de la présence de la sous-unité régulatrice Hap4p, homologue fonctionnel de PGC1α. Ce complexe transcriptionel est responsable de l’activation de l’expression de nombreux gènes codant pour les enzymes du cycle de Krebs, les enzymes de biosynthèse de l’hème et les enzymes de la chaine respiratoire. Nous nous sommes intéressés aux différentes voies de régulation de la biogénèse mitochondriale et ce, par l’étude de la régulation de la protéine Hap4p. Nos résultats sont les premiers à clairement mettre en évidence une régulation de Hap4p par l’hème labile. Nous avons également étudié le rôle de la répression glucose sur la biogénèse mitochondriale et avons pu mettre en évidence un parallèle avec l’effet Warburg mis en place dans les cellules cancéreuses. Nos résultats ont notamment montré une décorrélation entre le remodelage métabolique dû à l’effet Warburg et l’augmentation de la vitesse de prolifération. Cette étude suggère également que l’augmentation du flux glycolytique n’a pas pour conséquence une augmentation de la production d’ATP dans les cellules. L’ensemble de ce travail permet un apport supplémentaire dans la compréhension de l’effet Warburg et dans l’étude de la régulation de la biogénèse mitochondriale chez S. cerevisiae.
- 4 April 2026
- Published by Agence Bibliographique de l'Enseignement Supérieur
Étude de la régulation de la biogénèse mitochondriale chez la levure Saccharomyces cerevisiae
Dans la cellule, les fonctions cellulaires majeures, telles que la prolifération cellulaire, impliquent une consommation très importante d’énergie sous forme d’Adénosine Triphosphate (ATP). Pour répondre à l’augmentation de la demande énergétique, une production continuelle d’ATP est nécessaire. Dans ce contexte, les mitochondries sont les principaux producteurs d’ATP via le système des oxydations phosphorylantes (ou OXPHOS). Ce système couple l’activité de la chaine respiratoire (consommation d’oxygène) à celle de l’ATP synthase grâce au gradient électrochimique en protons de part et d’autre de la membrane interne mitochondriale. Ceci fait de la mitochondrie un élément central qui peut être régulé pour s’adapter aux demandes énergétiques de la cellule. En effet, une régulation cinétique de l’activité de la mitochondrie peut mener à une régulation plus globale du flux de production d’ATP tout comme une régulation du nombre de mitochondries au sein la cellule. Le réseau mitochondrial dans la cellule est géré par deux phénomènes : leur synthèse (biogénèse) et leur dégradation (ou mitophagie). Dans la souche de levure S. cerevisiae, la biogénèse mitochondriale est contrôlée par un hétérotétramère formé par les facteurs de transcription Hap2/3/4/5. L’activation du complexe dépend de la présence de la sous-unité régulatrice Hap4p, homologue fonctionnel de PGC1α. Ce complexe transcriptionel est responsable de l’activation de l’expression de nombreux gènes codant pour les enzymes du cycle de Krebs, les enzymes de biosynthèse de l’hème et les enzymes de la chaine respiratoire. Nous nous sommes intéressés aux différentes voies de régulation de la biogénèse mitochondriale et ce, par l’étude de la régulation de la protéine Hap4p. Nos résultats sont les premiers à clairement mettre en évidence une régulation de Hap4p par l’hème labile. Nous avons également étudié le rôle de la répression glucose sur la biogénèse mitochondriale et avons pu mettre en évidence un parallèle avec l’effet Warburg mis en place dans les cellules cancéreuses. Nos résultats ont notamment montré une décorrélation entre le remodelage métabolique dû à l’effet Warburg et l’augmentation de la vitesse de prolifération. Cette étude suggère également que l’augmentation du flux glycolytique n’a pas pour conséquence une augmentation de la production d’ATP dans les cellules. L’ensemble de ce travail permet un apport supplémentaire dans la compréhension de l’effet Warburg et dans l’étude de la régulation de la biogénèse mitochondriale chez S. cerevisiae.
- Open Access
- 20 January 2026
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 302 (3) , 111179
The antiseizure medication stiripentol inhibits mitochondrial complex I by blocking early-stage electron transfer
- 20 January 2026
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 302 (3) , 111179
Open AccessThe antiseizure medication stiripentol inhibits mitochondrial complex I by blocking early-stage electron transfer
- Open Access
Refining the Role of Pyruvate Dehydrogenase Kinases in Glioblastoma Development
Glioblastoma (GB) are the most frequent brain cancers. Aggressive growth and limited treatment options induce a median survival of 12–15 months. In addition to highly proliferative and invasive properties, GB cells show cancer-associated metabolic characteristics such as increased aerobic glycolysis. Pyruvate dehydrogenase (PDH) is a key enzyme complex at the crossroads between lactic fermentation and oxidative pathways, finely regulated by PDH kinases (PDHKs). PDHKs are often overexpressed in cancer cells to facilitate high glycolytic flux. We hypothesized that targeting PDHKs, by disturbing cancer metabolic homeostasis, would alter GB progression and render cells vulnerable to additional cancer treatment. Using patient databases, distinct expression patterns of PDHK1 and PDHK2 in GB tissues were obvious. To disturb protumoral glycolysis, we modulated PDH activity through the genetic or pharmacological inhibition of PDHK in patient-derived stem-like spheroids. Striking effects of PDHKs inhibition using dichloroacetate were observed in vitro on cell morphology and metabolism, resulting in increased intracellular ROS levels and decreased proliferation and invasion. In vivo findings confirmed a reduction in tumor size and better survival of mice implanted with PDHK1 and PDHK2 knockout cells. Adding a radiotherapeutic protocol further resulted in a reduction in tumor size and improved mouse survival in our model.
Open AccessRefining the Role of Pyruvate Dehydrogenase Kinases in Glioblastoma Development
Glioblastoma (GB) are the most frequent brain cancers. Aggressive growth and limited treatment options induce a median survival of 12–15 months. In addition to highly proliferative and invasive properties, GB cells show cancer-associated metabolic characteristics such as increased aerobic glycolysis. Pyruvate dehydrogenase (PDH) is a key enzyme complex at the crossroads between lactic fermentation and oxidative pathways, finely regulated by PDH kinases (PDHKs). PDHKs are often overexpressed in cancer cells to facilitate high glycolytic flux. We hypothesized that targeting PDHKs, by disturbing cancer metabolic homeostasis, would alter GB progression and render cells vulnerable to additional cancer treatment. Using patient databases, distinct expression patterns of PDHK1 and PDHK2 in GB tissues were obvious. To disturb protumoral glycolysis, we modulated PDH activity through the genetic or pharmacological inhibition of PDHK in patient-derived stem-like spheroids. Striking effects of PDHKs inhibition using dichloroacetate were observed in vitro on cell morphology and metabolism, resulting in increased intracellular ROS levels and decreased proliferation and invasion. In vivo findings confirmed a reduction in tumor size and better survival of mice implanted with PDHK1 and PDHK2 knockout cells. Adding a radiotherapeutic protocol further resulted in a reduction in tumor size and improved mouse survival in our model.
- Open Access
- 16 May 2022
- Published by Elsevier in STAR Protocols
- Vol. 3 (2) , 101403
NADH-independent enzymatic assay to quantify extracellular and intracellular L-lactate levels
- 16 May 2022
- Published by Elsevier in STAR Protocols
- Vol. 3 (2) , 101403
Open AccessNADH-independent enzymatic assay to quantify extracellular and intracellular L-lactate levels
- Top Cited Papers
- 1 November 2020
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Bioenergetics
- Vol. 1861 (11) , 148276
Cell energy metabolism: An update
- 1 November 2020
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Bioenergetics
- Vol. 1861 (11) , 148276
Top Cited PapersCell energy metabolism: An update
- Open Access
- 19 August 2020
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 10
The Warburg Effect in Yeast: Repression of Mitochondrial Metabolism Is Not a Prerequisite to Promote Cell Proliferation
O. Warburg conducted one of the first studies on tumor energy metabolism. His early discoveries pointed out that cancer cells display a decreased respiration and an increased glycolysis proportional to the increase in their growth rate, suggesting that they mainly depend on fermentative metabolism for ATP generation. Warburg's results and hypothesis generated controversies that are persistent to this day. It is thus of great importance to understand the mechanisms by which cancer cells can reversibly regulate the two pathways of their energy metabolism as well as the functioning of this metabolism in cell proliferation. Here, we made use of yeast as a model to study the Warburg effect and its eventual function in allowing an increased ATP synthesis to support cell proliferation. The role of oxidative phosphorylation repression in this effect was investigated. We show that yeast is a good model to study the Warburg effect, where all parameters and their modulation in the presence of glucose can be reconstituted. Moreover, we show that in this model, mitochondria are not dysfunctional, but that there are fewer mitochondria respiratory chain units per cell. Identification of the molecular mechanisms involved in this process allowed us to dissociate the parameters involved in the Warburg effect and show that oxidative phosphorylation repression is not mandatory to promote cell growth. Last but not least, we were able to show that neither cellular ATP synthesis flux nor glucose consumption flux controls cellular growth rate.
- 19 August 2020
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 10
Open AccessThe Warburg Effect in Yeast: Repression of Mitochondrial Metabolism Is Not a Prerequisite to Promote Cell Proliferation
O. Warburg conducted one of the first studies on tumor energy metabolism. His early discoveries pointed out that cancer cells display a decreased respiration and an increased glycolysis proportional to the increase in their growth rate, suggesting that they mainly depend on fermentative metabolism for ATP generation. Warburg's results and hypothesis generated controversies that are persistent to this day. It is thus of great importance to understand the mechanisms by which cancer cells can reversibly regulate the two pathways of their energy metabolism as well as the functioning of this metabolism in cell proliferation. Here, we made use of yeast as a model to study the Warburg effect and its eventual function in allowing an increased ATP synthesis to support cell proliferation. The role of oxidative phosphorylation repression in this effect was investigated. We show that yeast is a good model to study the Warburg effect, where all parameters and their modulation in the presence of glucose can be reconstituted. Moreover, we show that in this model, mitochondria are not dysfunctional, but that there are fewer mitochondria respiratory chain units per cell. Identification of the molecular mechanisms involved in this process allowed us to dissociate the parameters involved in the Warburg effect and show that oxidative phosphorylation repression is not mandatory to promote cell growth. Last but not least, we were able to show that neither cellular ATP synthesis flux nor glucose consumption flux controls cellular growth rate.
- Open Access
- 1 April 2020
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 295 (15) , 5095-5109
“Labile” heme critically regulates mitochondrial biogenesis through the transcriptional co-activator Hap4p in Saccharomyces cerevisiae
- 1 April 2020
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 295 (15) , 5095-5109
Open Access“Labile” heme critically regulates mitochondrial biogenesis through the transcriptional co-activator Hap4p in Saccharomyces cerevisiae
- 1 July 2019
- Vol. 33 (4) , 1097-1103
INHIBITION OF MITOCHONDRIAL CYTOCHROME C OXIDASE BY METABOLIZED NOBILETIN IN YEAST
- 1 July 2019
- Vol. 33 (4) , 1097-1103
INHIBITION OF MITOCHONDRIAL CYTOCHROME C OXIDASE BY METABOLIZED NOBILETIN IN YEAST
- Open Access
Mitochondrial Biogenesis and Mitochondrial Reactive Oxygen Species (ROS): A Complex Relationship Regulated by the cAMP/PKA Signaling Pathway
Mitochondrial biogenesis is a complex process. It requires the contribution of both the nuclear and the mitochondrial genomes and therefore cross talk between the nucleus and mitochondria. Cellular energy demand can vary by great length and it is now well known that one way to adjust adenosine triphosphate (ATP) synthesis to energy demand is through modulation of mitochondrial content in eukaryotes. The knowledge of actors and signals regulating mitochondrial biogenesis is thus of high importance. Here, we review the regulation of mitochondrial biogenesis both in yeast and in mammalian cells through mitochondrial reactive oxygen species.
Open AccessMitochondrial Biogenesis and Mitochondrial Reactive Oxygen Species (ROS): A Complex Relationship Regulated by the cAMP/PKA Signaling Pathway
Mitochondrial biogenesis is a complex process. It requires the contribution of both the nuclear and the mitochondrial genomes and therefore cross talk between the nucleus and mitochondria. Cellular energy demand can vary by great length and it is now well known that one way to adjust adenosine triphosphate (ATP) synthesis to energy demand is through modulation of mitochondrial content in eukaryotes. The knowledge of actors and signals regulating mitochondrial biogenesis is thus of high importance. Here, we review the regulation of mitochondrial biogenesis both in yeast and in mammalian cells through mitochondrial reactive oxygen species.
- 1 January 2019
- Published by Elsevier
- p. 3-32
Mitochondria: Ultrastructure, Dynamics, Biogenesis and Main Functions
- 1 January 2019
- Published by Elsevier
- p. 3-32
Mitochondria: Ultrastructure, Dynamics, Biogenesis and Main Functions